Article citationsMore>>
Al-Batran, S.E., Lorenzen, S., Thuss-Patience, P.C., Homann, N., Schenk, M., Lindig, U., et al. (2022) Surgical and Pathological Outcome, and Pathological Regression, in Patients Receiving Perioperative Atezolizumab in Combination with FLOT Chemotherapy versus FLOT Alone for Resectable Esophagogastric Adenocarcinoma: Interim Results from DANTE, a Randomized, Multicenter, Phase IIb Trial of the FLOT-AIO German Gastric Cancer Group and Swiss SAKK. Journal of Clinical Oncology, 40, 4003-4003.
https://doi.org/10.1200/JCO.2022.40.16_suppl.4003
has been cited by the following article:
-
TITLE:
Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
AUTHORS:
Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding
KEYWORDS:
Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.11 No.3,
March
30,
2023
ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.
Related Articles:
-
Daniel Santa Mina, Paul Ritvo, Andrew G. Matthew, Ajay Rampersad, Helga Stein, Angela M. Cheung, John Trachtenberg, Shabbir M. H. Alibhai
-
Mohammed H. Goda, Mostafa Abdel Rahman, Emadeldin R. Matar
-
Tomoaki Torigoe, Atsuhiko Terakado, Yoshiyuki Suehara, Taketo Okubo, Tatsuya Takagi, Kazuo Kaneko, Yasuo Yazawa
-
Ghada Ezzat Eladawei, Rasha Mohamed Abdellatif, Sheref Mohamed El-Taher
-
Abeer Hafez, Tarek El-Gohary, Fouad Abutaleb